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Abstract.	
	
Based	 on	 the	 study	 of	 the	 prevalence	 of	 potential	 genealogical	 and	
antenatal	 factors	 the	 most	 informative	 ones	 were	 determined.	 Their	
prognostic	value	was	used	as	a	criterion	for	assessing	the	risk	of	developing	
dysplastic	 dependent	 pathology	 of	 the	 bronchopulmonary	 system	 in	
children.	Standardized	pathometric	 tabular	algorithm	was	developed	using	
the	 Wald’s	 sequential	 analysis	 modified	 by	 Hubler	 EV.	 An	 example	 of	 its	
application	at	 the	 individual	 level	was	presented.	The	given	algorithm	was	
verified	among	children	of	both	groups	using	the	inverse	method.	The	type	I	
error	rate	(there	was	a	high	risk	in	the	absence	of	pathology)	was	α=12.0%,	and	
the	type	II	error	rate	(there	was	a	low	risk	in	the	presence	of	pathology)	was	
β=9.8%.	 The	 specificity	 of	 the	 algorithm	 was	 91.2%	 and	 its	 sensitivity	 was	
88.0%	that	allows	us	to	recommend	it	for	using	in	the	system	of	medical	and	
social	monitoring.	
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Problem	statement	and	analysis	of	the	recent	research	
Comprehensive	 consideration	 of	 potential	 risk	 factors	 for	 bronchopulmonary	 dysplasia	
(BPD)	and	dysplastic	dependent	pathology	(DDP)	of	the	bronchopulmonary	system	(BPS)	in	children	
to	 introduce	 standardized	procedure	 for	 the	prediction	of	 these	diseases	 is	of	great	 relevance	 to	
social	medicine	[1,	3-5].	The	development	and	rapid	flow	of	information	on	the	pathogenic	aspects	
of	 these	 diseases	 actualize	 the	 need	 to	 develop	 and	 improve	 the	 medical	 and	 organizational	
accompaniment	as	well	as	to	adapt	the	existing	models	 for	providing	medical	care	that	 from	the	
standpoint	 of	 prevention	 approach	 can	 be	 implemented	 through	 the	 introduction	 of	 screening	
technologies	and	prediction	algorithms	[6,	9-11].	BPD	is	known	to	be	a	multifactorial	disease	with	
trigger	and	genetic	 factors	 including	environmental	ones	 [1,	3-5].	Damage	to	the	respiratory	tract	
in	 the	 neonatal	 period	 may	 affect	 lung	 ontogenesis	 and	 under	 certain	 conditions	 determine	
consequences	of	the	disease	[6,	7].	Therefore,	the	study	of	BPD	in	the	continuing	lung	ontogenesis	
is	important	to	prevent	unfavorable	outcomes,	the	development	of	DDP	of	the	BPS	in	adulthood	in	
particular	 [8,	9].	The	question	of	predicting	risk	of	BPD	and	DDP	of	the	BPS	considering	antenatal	
and	 genealogical	 factors	 remains	 open	 [5,	 6,	 10,	 11].	 In	 this	 context,	 the	 development	 of	
standardized	algorithm	for	assessing	antenatal	and	genealogical	factors	is	relevant.		
The	 objective	 of	 the	 research	 was	 to	 provide	 evidence-based	 (clinical	 and	 statistical)	
justification	 of	 the	 risk	 assessment	 algorithm	 considering	 the	 complex	 of	 antenatal	 and	
genealogical	 factors	 being	 important	 for	 assessing	 children’s	 health	 in	 dysplastic	 dependent	
pathology	of	the	bronchopulmonary	system.	
	
Material	and	methods	
The	 complex	 of	 antenatal	 and	 genealogical	 risk	 factors	 for	 BPD	 and	 DDP	 of	 the	
bronchopulmonary	 system	 was	 used.	 The	 study	 of	 their	 frequency	 in	 groups	 of	 children	 (252	
persons	with	BPD	and	252	persons	without	BPD)	with	further	determination	of	the	informative	and	
prognostic	values	of	each	factor	in	relation	to	their	use	in	the	system	of	the	population-based	risk	
estimation	was	performed.	Personalized	analysis	of	the	existing	antenatal	and	genealogical	factors	
in	116	children	with	BPD	and	136	children	with	DDP	of	the	BPS	from	two	administrative	regions	of	
Ukraine	 (the	 first	stratified	population	sample	–	SPS1),	252	healthy	children	 (the	second	stratified	
population	sample	–	SPS2)	was	made.	When	studying	antenatal	and	genealogical	factors	specially	
prepared	 medical	 reports	 of	 expert	 evidence	 were	 used.	 Being	 completed	 for	 each	 patient	 they	
contained	 information	on	 the	presence	of	BPD	or	DDP	of	 the	BPS	 as	well	 as	 information	on	 the	
investigated	 factors	 obtained	 through	 interviews	 with	 parents	 using	 documented	 enclosed	
questionnaires	completed	by	parents:	the	incidence	of	a	complicated	course	of	pregnancy	(X31);	the	
age	of	the	mother	at	the	birth	of	her	child	(X32);	previous	terminations	of	pregnancy	in	the	mother	
(X33);	the	presence	of	stigmata	of	dysembryogenesis	in	previous	children	(X34);	the	presence	of	early	
and/or	 late	 gestosis	 during	 pregnancy	 (X35);	 maternal	 smoking	 in	 the	 first	 trimester	 of	
pregnancy/the	period	of	gestation	(X36);	the	presence	of	connective	tissue	disorders	in	the	mother	
(X37);	the	presence	of	chronic	somatic	diseases	in	the	father	(X38);	the	presence	of	chronic	somatic	
diseases	 in	 the	mother	 (X39);	 the	presence	 of	 connective	 tissue	disorders	 in	 the	 father	 (X40);	 the	
presence	of	connective	non-specific	diseases	 in	 the	mother	 (X41);	 the	presence	of	cardiovascular	
diseases	 in	 the	mother	 (X42),	etc.	The	 frequency,	prognostic	 coefficient	and	 informative	value	of	
certain	 factors	 were	 determined	 (using	 mathematical	 apparatus	 of	 variance	 analysis)	 for	 each	
investigated	 factor	 when	 making	 their	 comparative	 analysis	 in	 population-based	 samples	 of	
children	from	certain	select	areas	of	Dnipropetrovsk	and	Kharkiv	regions.	When	making	medical	
and	 statistical	 analysis	 (the	 one-way	 ANOVA)	 of	 factors	 frequency	 distribution	 of	 each	 factor	
gradation	 was	 used	 (Table	 1).	 The	 informative	 values	 of	 factors	 (I,	 bit),	 their	 effect	 size	 (η2,	%),	
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pathometric	prognostic	coefficients	 (PCP)	 as	 well	 as	 the	 statistically	 significant	 difference	 in	 the	
average	 indicators	were	calculated	using	the	Wald’s	sequential	analysis	modified	by	Hubler	EV	[2,	
3].		
Results	and	discussion	
According	to	the	results	of	comparative	analysis	of	20	antenatal	and	genealogical	factors	
(Table	 1	 presents	 the	 most	 significant	 ones)	 10	 factors	 being	 the	 most	 informative	 were	
determined	 using	 standardized	 procedure.	 Their	 prognostic	 values	 were	 calculated	 [12];	
standardized	algorithm	for	predicting	risk	of	DDP	of	the	BPS	in	children	was	processed	(Table	2).	
	
Table	1	
Genealogical	and	antenatal	factors	in	children	with	dysplastic	dependent	pathology	of	the	
bronchopulmonary	system	
C
оd
e	
o
f	f
ac
to
r	
Medical	and	biological,	
phenotypic	and	genealogical	
factors	
Population	samples	
PC,	
pat	
I,		
bit	
η2,		
%	
n1=252	
SPS1	
n1-C=252	
SCP2	
Indicators	 Gradations	 abs.		 Р±m	(%)	 abs.		 Р±m	(%)	
Х31	
Complicated	course		
of	pregnancy	
present	 224	 88.9±2.0	 127	 50.4±3.1	 +2.4	 0.474	
17	absent	 28	 11.1±2.0	 125	 49.6±3.1	 -6.5	 1.251	
η2=17.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 1.725	
Х32	
Age	of	the	mother	at	the	
birth	of	her	child	
≤19	 41	 16.3±2.3	 11	 4.4±1.3	 +5.7	 0.340	
9	
20-29	 117	 46.4±3.1	 190	 75.4±2.7	 -2.1	 0.305	
30-39	 85	 33.7±3.0	 49	 19.4±2.5	 +2.4	 0.171	
≥40	 9	 3.6±1.2	 2	 0.8±0.6	 +6.5	 0.091	
η2=9	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.907	
Х33	
Previous	terminations	of	
pregnancy	
present	 167	 66.3±3.0	 106	 42.1±3.1	 +2.0	 0.239	
6	absent	 85	 33.7±3.0	 146	 57.9±3.1	 -2.3	 0.284	
η2=6.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.523	
Х34	
Stigmata	of	
dysembryogenesis	in	
children	
present	 59	 24.3±2.7	 19	 7.5±1.7	 +4.9	 0.391	
5	
absent		 193	 76.6±2.7	 133	 92.5±1.7	 -0.8	 0.065	
η2=5.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.456	
Х35	
Early	
or	late	gestosis	
present	 179	 71.9±2.9	 125	 49.6±3.1	 +1.6	 0.167	
5	absent	 73	 29.0±2.9	 127	 50.4±3.1	 -2.4	 0.258	
η2=5.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.425	
Х36	
Maternal	smoking	in	the	
first	trimester	of	
pregnancy	
present	 53	 21.0±2.6	 21	 8.3±1.7	 +4.0	 0.255	
3	
absent		 199	 79.0±2.6	 131	 91.7±1.7	 -0.6	 0.041	
η2=3.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.296	
Х37	
Connective	tissue	
disorders	in	the	mother	
present	 63	 25.0±2.7	 28	 11.1±2.0	 +3.5	 0.245	
3	absent		 189	 75.0±2.7	 224	 88.9±2.0	 -0.7	 0.051	
η2=3.0	 р<0.0001	 total	 252	 100.0	 252	 100.0	 -	 0.296	
Х38	 present	 227	 90.1±1.9	 196	 77.8±2.6	 +0.6	 0.039	 3	
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Chronic	somatic	
diseases	in	the		
father		
absent		 25	 9.9±1.9	 56	 22.2±2.6	 -3.5	 0.215	
η2=3.0	 р=0.001	 total	 252	 100.0	 252	 100.0	 -	 0.254	
Х39	
Chronic	somatic	disease	
in	the		
mother		
present	 204	 81.8±2.5	 172	 68.3±2.9	 +0.7	 0.047	
2	
absent		 48	 19.0±2.5	 80	 31.7±2.9	 -2.3	 0.141	
η2=2.0	 р<0.001	 total	 252	 100.0	 252	 100.0	 -	 0.188	
Х40	
Connective	tissue	
disorders	in	the		
father	
present	 75	 29.8±2.9	 42	 16.7±2.3	 +2.5	 0.165	
2	
	
absent		 177	 70.2±2.9	 210	 83.3±2.3	 -0.7	 0.049	
η2=2.0	 р<0.001	 total	 252	 100.0	 252	 100.0	 -	 0.214	
Х41	
Connective	non-specific	
diseases		
in	the	mother	
present	 47	 18.7±2.5	 21	 8.3±1.7	 +3.5	 0.180	
2	
absent		 205	 81.3±2.5	 231	 91.7±1.7	 -0.5	 0.027	
η2=2.0	 р<0.001	 total	 252	 100.0	 252	 100.0	 -	 0.207	
Х42	
CVD	
in	the	mother	
present	 59	 23.4±2.7	 33	 13.1±2.1	 +2.5	 0.130	
2	absent		 193	 76.6±2.7	 219	 86.9±2.1	 -0.5	 0.028	
η2=2.0	 р<0.003	 total	 252	 100.0	 914	 100.0	 -	 0.158	
Notes:	
η2	–	effect	size	of	the	factor,	%;	
I	–	informative	value	of	the	factor,	bit;	
PCp	-	pathometric	prognostic	coefficients	of	the	factor,	pat;	
p	–	the	level	of	statistical	significance.	
	
The	algorithm	was	based	on	using	prognostic	values	of	the	most	informative	factors	and	
had	a	table	equivalent	containing	the	indicators	of	the	assessment	–	prognostic	coefficients	(PC)	
and	 the	 rating	 scale	 as	 an	 outcome	 predictor.	 The	 algorithm	 involved	 independent	 signs	 of	
prediction	only.	When	the	strength	of	the	correlation	(±rxy)	between	two	factors	was	higher	than	
±0.70	one	of	 the	 factors	was	excluded	 from	 the	 list	of	 indicators.	 The	 use	 of	 tabular	 algorithm	
implemented	pathometric	approach	to	risk	assessment.	The	principle	of	arriving	at	a	predictive	
solution	 in	pathometric	algorithm	 (PA)	 reduced	 itself	 to	 the	addition	of	prognostic	 coefficients	
following	 the	 sequence	 while	 analyzing	 the	 indicators.	 PA	 is	 known	 to	 consider	 the	 existing	
indicators	 as	 well	 as	 to	 minimize	 the	 number	 of	 steps	 which	 might	 be	 taken	 by	 prognostic	
technology	due	to	the	use	of	informative	criteria	(Table	1).	
The	 following	 example	 shows	 the	 application	 of	 the	 algorithm:	 A	 40-year-old	 Olga	 N.	 is	
pregnant	(28	weeks	of	pregnancy).	To	predict	the	risk	of	developing	dysplastic	dependent	pathology	
in	her	child	considering	 the	complex	of	antenatal	and	genealogical	 factors	as	well	as	 the	data	of	
the	primary	healthcare	 records	and	 standardized	questionnaire	 completed	by	parents	 there	has	
been	 revealed	 the	 following:	 there	was	 a	 complicated	 course	 of	previous	pregnancy	 in	her	past	
medical	history	 (31PCP=+2.4	pat);	the	age	of	the	mother	at	the	moment	of	her	second	child’s	birth	
will	be	41	years	(32PCP=+6.5	pat);	 there	were	previous	 terminations	of	pregnancy	 (33PCP=+2.0	pat);	
her	 first	 child	 suffers	 from	 stigmata	 (hyperelastosis	 cutis)	of	dysembryogenesis	 (34PCP=+4.9	pat).	
The	 procedure	 of	 prediction	 was	 stopped	 as	 predictive	 threshold	 was	 reached:	 PT=	
(+2.4)+(+6.5)+(+2.0)+(+4.9)=+15.8	pat,	i.e.	PT>15.	Since	the	threshold	predictive	sum	was	reached	we	
can	predict	with	adequate	reliability	(in	PCmax	=+15	error	does	not	exceed	5.0%)	that	there	is	a	high	
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risk	of	developing	dysplastic	dependent	pathology	of	the	bronchopulmonary	system	in	her	second	
child		
Table	2	
Algorithm	for	predicting	dysplastic	dependent	pathology	of	the	bronchopulmonary	system	in	a	child	
considering	the	complex	of	antenatal	and	genealogical	factors	
Regional	and	environmental	factors	
Prognostic	coefficients	
Criterion	 PC	
1.	 Complicated	course	of	pregnancy	in	the	past	medical	history	
present	 +2.4	
absent	 -6.5	
2.	 Age	of	the	mother	at	the	moment	of	her	child’s	birth	
≤19	 +5.7	
20-29	 -2.1	
30-39	 +2.4	
≥40	 +6.5	
3.	 Previous	terminations	of	pregnancy	
present	 +2.0	
absent	 -2.3	
4.	 Stigmata	of	dysembryogenesis	in	the	child	
present	 +4.9	
absent	 -0.8	
5.	 Gestosis	(early	and/or	late)	
present	 +1.6	
absent	 -2.4	
6.	 Maternal	smoking	in	the	first	trimester	of	pregnancy	
present	 +4.0	
absent	 -0.6	
7.	 Dysplastic	dependent	pathology	in	the	mother	
present	 +3.5	
absent	 -0.7	
8.	 Chronic	somatic	diseases	in	the	father	
present	 +0.6	
absent	 -3.5	
9.	
Chronic	somatic	diseases	in	the	mother	
	
present	 +0.7	
absent	 -2.3	
10.	 Dysplastic	dependent	pathology	in	the	father	
present	 +2.5	
absent	 -0.7	
Note:	 pathomeric	 coefficients	 are	 determined	 for	 each	 factor	 and	 then,	 systematically	
added;	 when	 the	 threshold	 sum	 (TS)	 of	 coefficients	 is	 reached	 (-13	 or	 +13)	 the	 risk	 level	 is	
determined	using	the	scale.	
	
	
Rating	scale	for	assessing	the	risk	of	dysplastic	dependent	pathology	of	the	bronchopulmonary	
system	
TSmin	≤	–13.0	 	
uncertain	risk	
TSmax	≥	+13.0	
minimal		 high	risk		
	
Fig.	1.	Scale	of	personalized	risk	stratification	for	prevention	of	dysplastic	dependent	pathology	of	
the	bronchopulmonary	system	in	children	depending	on	the	impact	of	antenatal	and	genealogical	
factors.	
	
The	given	algorithm	was	verified	among	children	of	both	groups	 (252	children	with	DDP	
and	 252	 children	 without	 DDP).	 The	 type	 I	 error	 rate	 (there	 was	 a	 high	 risk	 in	 the	 absence	 of	
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pathology)	was	α=12.0%,	and	the	type	II	error	rate	(there	was	a	low	risk	in	the	presence	of	pathology)	
was	β=9.8%.	Thus,	the	specificity	of	the	algorithm	 is	91.2%	and	 its	sensitivity	 is	88.0%	allowing	us	
to	recommend	it	for	using	in	the	system	of	medical	and	social	monitoring.	
	
Conclusions	
1.	Based	on	 the	study	of	 the	prevalence	of	20	potential	genealogical	and	antenatal	 factors	
the	most	 informative	ones	were	determined.	Their	prognostic	 value	was	used	 as	 a	 criterion	 for	
assessing	the	risk	of	developing	DDP	of	the	bronchopulmonary	system	in	children.	
2.	Standardized	pathometric	tabular	algorithm	was	developed	using	the	Wald’s	sequential	
analysis	modified	by	Hubler	EV.	An	example	of	its	application	at	the	individual	level	was	presented.	
The	application	of	the	given	algorithm	allows	us	to	document	the	existent	significant	risk	factors	as	
well	as	to	identify	people	at	high	risk	of	DDP	of	the	bronchopulmonary	system.	
3.	 The	 given	 algorithm	 was	 verified	 among	 children	 of	 both	 groups	 using	 the	 inverse	
method.	The	type	I	error	rate	(there	was	a	high	risk	in	the	absence	of	pathology)	was	α=12.0%,	and	
the	type	II	error	rate	(there	was	a	low	risk	in	the	presence	of	pathology)	was	β=9.8%.	The	specificity	
of	the	algorithm	was	91.2%	and	its	sensitivity	was	88.0%	that	allows	us	to	recommend	it	for	using	in	
the	system	of	medical	and	social	monitoring.	
	
Prospects	 for	 further	 research	 are	 determined	 by	 the	 need	 to	 develop	 the	 system	 of	
population-based	 and	 individual	 prediction	 of	 DDP	 of	 the	 bronchopulmonary	 system	 in	 the	
antenatal	period	as	well	as	at	 the	 stages	of	postnatal	ontogenesis	considering	other	 informative	
(medical	and	organizational,	regional	and	environmental)	factors.	
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